HBeAg testing is better than quantitative HBsAg assay as an alternative to HBV DNA assay among HBV-infected pregnant women
Introduction: Using tenofovir disoproxil fumarate (TDF) is recommended in the 3rd trimester for pregnant women with HBV DNA ≥ 200,000 IU/mL to prevent mother-to-child transmission (MTCT) of hepatitis B virus (HBV). However, HBV DNA quantification is unavailable in many resource-limited areas worldw...
| الحاوية / القاعدة: | Journal of Infection in Developing Countries |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
The Journal of Infection in Developing Countries
2023-10-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://jidc.org/index.php/journal/article/view/17516 |
